- Home
- PLX vs BFIN Comparison
PLX vs BFIN Comparison
Compare PLX & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- BFIN
- Stock Information
- Founded
- PLX 1993
- BFIN 1924
- Country
- PLX United States
- BFIN United States
- Employees
- PLX N/A
- BFIN N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- BFIN Savings Institutions
- Sector
- PLX Health Care
- BFIN Finance
- Exchange
- PLX Nasdaq
- BFIN Nasdaq
- Market Cap
- PLX 122.6M
- BFIN 142.4M
- IPO Year
- PLX 1998
- BFIN N/A
- Fundamental
- Price
- PLX $1.54
- BFIN $11.86
- Analyst Decision
- PLX Strong Buy
- BFIN
- Analyst Count
- PLX 1
- BFIN 0
- Target Price
- PLX $15.00
- BFIN N/A
- AVG Volume (30 Days)
- PLX 1.2M
- BFIN 88.1K
- Earning Date
- PLX 08-13-2025
- BFIN 07-30-2025
- Dividend Yield
- PLX N/A
- BFIN 3.43%
- EPS Growth
- PLX N/A
- BFIN N/A
- EPS
- PLX 0.05
- BFIN 0.36
- Revenue
- PLX $59,764,000.00
- BFIN $48,547,000.00
- Revenue This Year
- PLX $65.02
- BFIN $1.43
- Revenue Next Year
- PLX $57.34
- BFIN $4.33
- P/E Ratio
- PLX $31.98
- BFIN $32.72
- Revenue Growth
- PLX 0.18
- BFIN N/A
- 52 Week Low
- PLX $0.82
- BFIN $10.01
- 52 Week High
- PLX $3.10
- BFIN $13.97
- Technical
- Relative Strength Index (RSI)
- PLX 47.41
- BFIN 55.41
- Support Level
- PLX $1.32
- BFIN $11.48
- Resistance Level
- PLX $1.67
- BFIN $11.84
- Average True Range (ATR)
- PLX 0.11
- BFIN 0.30
- MACD
- PLX 0.04
- BFIN 0.06
- Stochastic Oscillator
- PLX 62.86
- BFIN 93.94
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About BFIN BankFinancial Corporation
BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.